{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infection+Prophylaxis&page=52",
    "query": {
      "condition": "Infection Prophylaxis",
      "page": 52
    },
    "page_size": 10
  },
  "pagination": {
    "page": 52,
    "page_size": 10,
    "total_count": 1281,
    "total_pages": 129,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infection+Prophylaxis&page=53&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infection+Prophylaxis&page=51&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-11-11T18:04:42.695Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT00447720",
      "title": "HIV Prevention Among Substance Abusing SMI",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Mentally Ill Persons",
        "Substance Abuse",
        "HIV Infections"
      ],
      "interventions": [
        {
          "name": "PATH",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "University of Pennsylvania",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 238,
      "start_date": "2004-06",
      "completion_date": "2008-06",
      "has_results": false,
      "last_update_posted_date": "2015-12-03",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 1,
      "location_summary": "Philadelphia, Pennsylvania",
      "locations": [
        {
          "city": "Philadelphia",
          "state": "Pennsylvania"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00447720"
    },
    {
      "nct_id": "NCT00113191",
      "title": "Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Nosocomial Infections",
        "Sepsis",
        "Staphylococcal Infections",
        "Candidemia"
      ],
      "interventions": [
        {
          "name": "Veronate",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Bristol-Myers Squibb",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "3 Days",
        "maximum_age": "5 Days",
        "sex": "ALL",
        "summary": "3 Days to 5 Days"
      },
      "enrollment_count": 2000,
      "start_date": "2004-05",
      "completion_date": "2006-06",
      "has_results": false,
      "last_update_posted_date": "2012-08-02",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 85,
      "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 71 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Anchorage",
          "state": "Alaska"
        },
        {
          "city": "Phoenix",
          "state": "Arizona"
        },
        {
          "city": "Phoenix",
          "state": "Arizona"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00113191"
    },
    {
      "nct_id": "NCT04478474",
      "title": "Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Cytomegalovirus Infections"
      ],
      "interventions": [
        {
          "name": "Ganciclovir",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "New York Medical College",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "26 Years",
        "sex": "ALL",
        "summary": "Up to 26 Years"
      },
      "enrollment_count": 100,
      "start_date": "2020-09-15",
      "completion_date": "2022-09-15",
      "has_results": false,
      "last_update_posted_date": "2023-10-26",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 1,
      "location_summary": "Valhalla, New York",
      "locations": [
        {
          "city": "Valhalla",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04478474"
    },
    {
      "nct_id": "NCT01381848",
      "title": "A Study of Doripenem in Infants Less Than 12 Weeks of Age",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Bacterial Infections"
      ],
      "interventions": [
        {
          "name": "Doripenem",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Janssen Research & Development, LLC",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "12 Weeks",
        "sex": "ALL",
        "summary": "Up to 12 Weeks"
      },
      "enrollment_count": 52,
      "start_date": "2009-10",
      "completion_date": "2012-04",
      "has_results": false,
      "last_update_posted_date": "2013-01-10",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 7,
      "location_summary": "Little Rock, Arkansas • Orange, California • Royal Oak, Michigan + 4 more",
      "locations": [
        {
          "city": "Little Rock",
          "state": "Arkansas"
        },
        {
          "city": "Orange",
          "state": "California"
        },
        {
          "city": "Royal Oak",
          "state": "Michigan"
        },
        {
          "city": "New Brunswick",
          "state": "New Jersey"
        },
        {
          "city": "Toledo",
          "state": "Ohio"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01381848"
    },
    {
      "nct_id": "NCT06406049",
      "title": "Finishing HIV Project",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hiv"
      ],
      "interventions": [
        {
          "name": "Control group-Standard Health Promotion",
          "type": "OTHER"
        },
        {
          "name": "Social network intervention",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "OTHER",
        "BEHAVIORAL"
      ],
      "sponsor": "University of Miami",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "54 Years",
        "sex": "MALE",
        "summary": "18 Years to 54 Years · Male only"
      },
      "enrollment_count": 624,
      "start_date": "2024-11-08",
      "completion_date": "2030-05-31",
      "has_results": false,
      "last_update_posted_date": "2026-04-20",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 1,
      "location_summary": "Miami, Florida",
      "locations": [
        {
          "city": "Miami",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06406049"
    },
    {
      "nct_id": "NCT00000638",
      "title": "Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "HIV Infections",
        "Tuberculosis"
      ],
      "interventions": [
        {
          "name": "Isoniazid",
          "type": "DRUG"
        },
        {
          "name": "Pyrazinamide",
          "type": "DRUG"
        },
        {
          "name": "Pyridoxine hydrochloride",
          "type": "DRUG"
        },
        {
          "name": "Rifampin",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "13 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "13 Years and older"
      },
      "enrollment_count": 2000,
      "start_date": null,
      "completion_date": "1999-09",
      "has_results": false,
      "last_update_posted_date": "2021-11-02",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 75,
      "location_summary": "Birmingham, Alabama • Los Angeles, California • Oakland, California + 39 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Oakland",
          "state": "California"
        },
        {
          "city": "San Francisco",
          "state": "California"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00000638"
    },
    {
      "nct_id": "NCT00103896",
      "title": "Connect to Protect Partnerships for Youth Prevention Interventions: Phase II",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "HIV Infection"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "University of North Carolina, Chapel Hill",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "12 Years",
        "maximum_age": "24 Years",
        "sex": "ALL",
        "summary": "12 Years to 24 Years"
      },
      "enrollment_count": 16706,
      "start_date": "2003-09",
      "completion_date": "2010-10",
      "has_results": false,
      "last_update_posted_date": "2017-03-01",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 14,
      "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 11 more",
      "locations": [
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "San Diego",
          "state": "California"
        },
        {
          "city": "San Francisco",
          "state": "California"
        },
        {
          "city": "Washington D.C.",
          "state": "District of Columbia"
        },
        {
          "city": "Fort Lauderdale",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00103896"
    },
    {
      "nct_id": "NCT05853120",
      "title": "Doxy-Post-exposure Prophylaxis",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Sexually Transmitted Diseases"
      ],
      "interventions": [
        {
          "name": "Doxycycline",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Emory University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "59 Years",
        "sex": "ALL",
        "summary": "18 Years to 59 Years"
      },
      "enrollment_count": 45,
      "start_date": "2023-05-31",
      "completion_date": "2024-12-24",
      "has_results": true,
      "last_update_posted_date": "2025-09-11",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 1,
      "location_summary": "Atlanta, Georgia",
      "locations": [
        {
          "city": "Atlanta",
          "state": "Georgia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05853120"
    },
    {
      "nct_id": "NCT01142882",
      "title": "Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "HIV Infections",
        "Hepatitis",
        "Sexually Transmitted Infections"
      ],
      "interventions": [
        {
          "name": "Traditional Prevention",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Web-based Prevention",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "National Development and Research Institutes, Inc.",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "12 Years",
        "maximum_age": "18 Years",
        "sex": "ALL",
        "summary": "12 Years to 18 Years"
      },
      "enrollment_count": 120,
      "start_date": "2010-02",
      "completion_date": "2011-08",
      "has_results": false,
      "last_update_posted_date": "2011-07-20",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 3,
      "location_summary": "Brooklyn, New York • Jamaica, New York • The Bronx, New York",
      "locations": [
        {
          "city": "Brooklyn",
          "state": "New York"
        },
        {
          "city": "Jamaica",
          "state": "New York"
        },
        {
          "city": "The Bronx",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01142882"
    },
    {
      "nct_id": "NCT02897804",
      "title": "Engineering an Online STI Prevention Program",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sexual Behavior",
        "Alcohol Consumption",
        "Sexually Transmitted Diseases"
      ],
      "interventions": [
        {
          "name": "Knowledge alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Self-efficacy alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Perceived benefits alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Perceived benefits and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms, perceived benefits, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms,perceived benefits,self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms, injunctive norms,self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, benefits,efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and Perceived Benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, perceived benefits, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and descriptive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, and benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies,descriptive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descr& injun norms, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, desc & injun norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies,desc & injun norms,benefits,efficacy",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Penn State University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "30 Years",
        "sex": "ALL",
        "summary": "18 Years to 30 Years"
      },
      "enrollment_count": 3997,
      "start_date": "2016-08",
      "completion_date": "2017-06",
      "has_results": false,
      "last_update_posted_date": "2019-01-09",
      "last_synced_at": "2026-11-11T18:04:42.695Z",
      "location_count": 4,
      "location_summary": "Fresno, California • Carbondale, Illinois • Greensboro, North Carolina + 1 more",
      "locations": [
        {
          "city": "Fresno",
          "state": "California"
        },
        {
          "city": "Carbondale",
          "state": "Illinois"
        },
        {
          "city": "Greensboro",
          "state": "North Carolina"
        },
        {
          "city": "Fargo",
          "state": "North Dakota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02897804"
    }
  ]
}